These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 15848008)
21. Monodisperse chitosan nanoparticles for mucosal drug delivery. Zhang H; Oh M; Allen C; Kumacheva E Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064 [TBL] [Abstract][Full Text] [Related]
22. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of chitosan tripolyphosphate nanoparticles and its encapsulation efficiency containing Russell's viper snake venom. Venkatesan C; Vimal S; Hameed AS J Biochem Mol Toxicol; 2013 Aug; 27(8):406-11. PubMed ID: 23712553 [TBL] [Abstract][Full Text] [Related]
24. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248 [TBL] [Abstract][Full Text] [Related]
25. Development and characterisation of chitosan nanoparticles for siRNA delivery. Katas H; Alpar HO J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358 [TBL] [Abstract][Full Text] [Related]
26. Quaternized chitosan/alginate nanoparticles for protein delivery. Li T; Shi XW; Du YM; Tang YF J Biomed Mater Res A; 2007 Nov; 83(2):383-90. PubMed ID: 17450586 [TBL] [Abstract][Full Text] [Related]
27. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Xu Y; Du Y Int J Pharm; 2003 Jan; 250(1):215-26. PubMed ID: 12480287 [TBL] [Abstract][Full Text] [Related]
28. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Fan W; Yan W; Xu Z; Ni H Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934 [TBL] [Abstract][Full Text] [Related]
29. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762 [TBL] [Abstract][Full Text] [Related]
30. Stability of chitosan nanoparticles cross-linked with tripolyphosphate. Jonassen H; Kjøniksen AL; Hiorth M Biomacromolecules; 2012 Nov; 13(11):3747-56. PubMed ID: 23046433 [TBL] [Abstract][Full Text] [Related]
31. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles. Rajan M; Raj V; Al-Arfaj AA; Murugan AM Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828 [TBL] [Abstract][Full Text] [Related]
32. Novel self-aggregates of chitosan oligosaccharide grafted stearic acid: preparation, characterization and protein association. Hu FQ; Li YH; Yuan H; Zeng S Pharmazie; 2006 Mar; 61(3):194-8. PubMed ID: 16599258 [TBL] [Abstract][Full Text] [Related]
33. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Haidar ZS; Hamdy RC; Tabrizian M Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987 [TBL] [Abstract][Full Text] [Related]
34. Positively charged amphiphilic chitosan derivative for the transscleral delivery of rapamycin. Elsaid N; Jackson TL; Gunic M; Somavarapu S Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8105-11. PubMed ID: 23049091 [TBL] [Abstract][Full Text] [Related]
35. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin. Sun W; Mao S; Mei D; Kissel T Eur J Pharm Biopharm; 2008 Jun; 69(2):417-25. PubMed ID: 18294825 [TBL] [Abstract][Full Text] [Related]
36. Encapsulation of ascorbyl palmitate in chitosan nanoparticles by oil-in-water emulsion and ionic gelation processes. Yoksan R; Jirawutthiwongchai J; Arpo K Colloids Surf B Biointerfaces; 2010 Mar; 76(1):292-7. PubMed ID: 20004558 [TBL] [Abstract][Full Text] [Related]
37. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells. Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of chitosan-stabilized gold nanoparticles in the absence/presence of tripolyphosphate. Huang H; Yang X Biomacromolecules; 2004; 5(6):2340-6. PubMed ID: 15530050 [TBL] [Abstract][Full Text] [Related]
39. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane. Singh KH; Shinde UA Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982 [TBL] [Abstract][Full Text] [Related]
40. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers. Chen F; Zhang ZR; Huang Y Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]